Show simple item record

dc.contributor.authorRussell, AE
dc.contributor.authorFord, T
dc.contributor.authorGunnell, D
dc.contributor.authorHeron, J
dc.contributor.authorJoinson, C
dc.contributor.authorMoran, P
dc.contributor.authorRelton, C
dc.contributor.authorSuderman, M
dc.contributor.authorHemani, G
dc.contributor.authorMars, B
dc.date.accessioned2020-07-06T14:09:54Z
dc.date.issued2020-05-28
dc.description.abstractBackground: The causal role of inflammatory markers on self-harm and suicidal risk has been studied using observational data, with conflicting results. Confounding and reverse causation can lead to bias, so we appraised question from a genetic perspective to protect against these biases. We measured associations between genetic liability for high levels of inflammatory markers Interleukin-6 (IL-6) and C-reactive protein (CRP) on self-harm, and conducted a secondary analysis restricted to self-harm with suicidal intent. Methods: We conducted two sample and multivariable Mendelian randomisation (MR) to assess the effects of IL-6 and CRP on self-harm utilising existing data and conducting new genome wide association studies to instrument IL-6 and CRP, and for the outcome of self-harm. Results: No single nucleotide polymorphisms (SNPs) reached genome-wide significance for self-harm, however 193 SNPs met suggestive significance levels (p < 5 × 10−6). We found no evidence of an association between our instruments for IL-6 and self-harm in the two-sample MR, however we found an inverse association between instruments for CRP and self-harm, indicating that higher levels of circulating CRP may protect against self-harm (inverse variance weighted OR 0.92, 95%CI 0.84, 1.01, p = 0.08; MR Egger OR 0.86, 95% CI 0.74, 1.00, p = 0.05). The direct effect estimate for IL-6 was slightly smaller in the multivariable MR than in the two sample MR, while the CRP effect estimates were consistent with the two sample MR (OR 0.92, SE 1.05, p = 0.09). Conclusions: Our findings are conflicting and indicate that IL-6 and CRP are not robust etiological markers of increased self-harm or suicide risk.en_GB
dc.description.sponsorshipMedical Research Council (MRC)en_GB
dc.description.sponsorshipWellcome Trusten_GB
dc.description.sponsorshipNational Institute for Health Research (NIHR)en_GB
dc.identifier.citationPublished online 28 May 2020en_GB
dc.identifier.doi10.1016/j.bbi.2020.05.065
dc.identifier.grantnumberMR/R004889/1en_GB
dc.identifier.grantnumber102215/2/13/2en_GB
dc.identifier.grantnumberGR067797MAen_GB
dc.identifier.urihttp://hdl.handle.net/10871/121798
dc.language.isoenen_GB
dc.publisherElsevieren_GB
dc.rights© 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/).en_GB
dc.subjectC-reactive proteinen_GB
dc.subjectself harmen_GB
dc.subjectsuicideen_GB
dc.subjectMendelian Randomisationen_GB
dc.subjectInflammationen_GB
dc.subjectInterleukin-6en_GB
dc.titleInvestigating evidence for a causal association between inflammation and self-harm: A multivariable Mendelian Randomisation studyen_GB
dc.typeArticleen_GB
dc.date.available2020-07-06T14:09:54Z
dc.identifier.issn0889-1591
dc.descriptionThis is the final version. Available on open access from Elsevier via the DOI in this recorden_GB
dc.identifier.journalBrain, Behavior, and Immunityen_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2020-05-24
exeter.funder::Medical Research Council (MRC)en_GB
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2020-05-24
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2020-07-06T13:59:08Z
refterms.versionFCDAM
refterms.dateFOA2020-07-15T14:31:25Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/).
Except where otherwise noted, this item's licence is described as © 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/).